David Siegel Selected Research

Superoxides (Superoxide)

8/2008	Comparison effect of atorvastatin (10 versus 80 mg) on biomarkers of inflammation and oxidative stress in subjects with metabolic syndrome.
12/2007	Coumarin-based inhibitors of human NAD(P)H:quinone oxidoreductase-1. Identification, structure-activity, off-target effects and in vitro human pancreatic cancer toxicity.
7/2006	5-Methoxy-1,2-dimethyl-3-[(4-nitrophenoxy)methyl]indole-4,7-dione, a mechanism-based inhibitor of NAD(P)H:quinone oxidoreductase 1, exhibits activity against human pancreatic cancer in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David Siegel Research Topics

Disease

58	Multiple Myeloma 04/2024 - 03/2002
26	Neoplasms (Cancer) 05/2024 - 03/2002
12	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 11/2007
8	Hypertension (High Blood Pressure) 01/2019 - 01/2007
8	Pancreatic Neoplasms (Pancreatic Cancer) 07/2014 - 07/2006
7	Leukemia 01/2016 - 08/2004
6	Hematologic Neoplasms (Hematological Malignancy) 04/2024 - 07/2009
6	Breast Neoplasms (Breast Cancer) 01/2020 - 11/2005
6	Inflammation (Inflammations) 10/2016 - 08/2008
5	Insulin Resistance 11/2020 - 09/2007
4	Diabetes Mellitus 01/2019 - 06/2003
3	Fatigue 06/2020 - 07/2009
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2017 - 11/2012
3	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2015 - 04/2013
3	Carcinoma (Carcinomatosis) 11/2003 - 03/2003
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2020 - 01/2020
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2020 - 01/2020
2	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 07/2009
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020 - 06/2010
2	Neutropenia 01/2020 - 11/2007
2	Diarrhea 01/2020 - 07/2009
2	Nausea 01/2020 - 07/2009
2	Vomiting 01/2020 - 07/2009
2	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2019 - 01/2018
2	Obesity 01/2017 - 10/2016
2	Lymphoma (Lymphomas) 01/2016 - 12/2008
2	Heart Failure 11/2013 - 06/2003
2	Atherosclerosis 04/2013 - 02/2011
2	Aneurysm (Aneurysms) 12/2012 - 05/2011
2	Type 2 Diabetes Mellitus (MODY) 04/2011 - 06/2002
2	Disease Progression 02/2011 - 07/2009
2	Chromosome Aberrations (Chromosome Abnormalities) 10/2006 - 05/2003
1	Myeloid Leukemia (Leukemia, Myelocytic) 05/2024
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 05/2024
1	Mitochondrial Diseases (Mitochondrial Disease) 05/2024
1	Skin Neoplasms (Skin Cancer) 11/2023

Drug/Important Bio-Agent (IBA)

18	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023 - 03/2002
16	carfilzomibIBA 01/2023 - 06/2011
15	quinone (benzoquinone)IBA 10/2016 - 05/2003
13	Proteins (Proteins, Gene)FDA Link 11/2020 - 03/2003
10	Lenalidomide (CC 5013)FDA Link 01/2022 - 10/2007
10	NAD (NADH)IBA 10/2016 - 05/2003
10	Oxidoreductases (Dehydrogenase)IBA 10/2016 - 05/2003
7	Biomarkers (Surrogate Marker)IBA 01/2023 - 08/2008
7	selinexorIBA 09/2021 - 01/2018
7	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 06/2002
7	C-Reactive ProteinIBA 01/2019 - 10/2006
6	Bortezomib (Velcade)FDA Link 01/2020 - 06/2003
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 11/2007
6	EnzymesIBA 01/2017 - 07/2006
5	daratumumabIBA 01/2023 - 01/2020
5	tanespimycin (17AAG)IBA 12/2015 - 11/2005
5	IndolequinonesIBA 07/2014 - 05/2007
4	Proteasome InhibitorsIBA 02/2021 - 11/2013
4	Insulin (Novolin)FDA Link 01/2021 - 02/2012
4	Dicumarol (Dicoumarol)FDA Link 01/2012 - 07/2006
4	Antihypertensive Agents (Antihypertensives)IBA 07/2011 - 01/2007
4	Benzene (Benzole)IBA 06/2011 - 08/2004
3	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2023 - 01/2019
3	Chimeric Antigen ReceptorsIBA 01/2023 - 01/2019
3	B-Cell Maturation AntigenIBA 01/2021 - 01/2019
3	LipidsIBA 11/2020 - 08/2008
3	Messenger RNA (mRNA)IBA 01/2020 - 10/2016
3	Rifabutin (Ansamycin)FDA Link 12/2015 - 04/2012
3	Thalidomide (Thalomid)FDA Link 01/2014 - 11/2007
3	Heat-Shock Proteins (Heat-Shock Protein)IBA 04/2013 - 03/2011
3	Antineoplastic Agents (Antineoplastics)IBA 04/2012 - 07/2009
3	NRH - quinone oxidoreductase2IBA 08/2011 - 12/2008
3	Blood Glucose (Blood Sugar)IBA 04/2011 - 06/2002
3	Superoxides (Superoxide)IBA 08/2008 - 07/2006
2	Monoclonal AntibodiesIBA 02/2021 - 11/2013
2	Immunomodulating AgentsIBA 02/2021 - 01/2014
2	idecabtagene vicleucelIBA 01/2021 - 01/2019
2	Exportin 1 ProteinIBA 01/2020 - 01/2018
2	Simvastatin (Zocor)FDA LinkGeneric 01/2019 - 11/2007
2	LDL CholesterolIBA 08/2017 - 08/2008
2	oxidized low density lipoproteinIBA 08/2017 - 08/2008
2	pomalidomideIBA 06/2017 - 03/2013
2	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2017 - 10/2016
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2016 - 07/2013
2	geldanamycinIBA 12/2015 - 04/2013
2	AdiponectinIBA 12/2014 - 11/2007
2	Histone Deacetylase InhibitorsIBA 01/2014 - 07/2009
2	PanobinostatIBA 10/2013 - 09/2012
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 03/2012 - 06/2003
2	Thioredoxin-Disulfide ReductaseIBA 03/2012 - 07/2009
2	Angiotensin Receptor AntagonistsIBA 03/2012 - 06/2003
2	PotassiumIBA 07/2011 - 04/2008
2	Macrocyclic LactamsIBA 05/2011 - 10/2006
2	LDL Lipoproteins (beta Lipoproteins)IBA 02/2011 - 08/2008
2	Vorinostat FDA Link 07/2009 - 03/2008
2	indoleIBA 07/2009 - 07/2006
1	Tyrosine Kinase InhibitorsIBA 05/2024
1	VaccinesIBA 05/2024
1	CalciumIBA 05/2024
1	Immunoglobulins (Immunoglobulin)IBA 04/2024

Therapy/Procedure

28	Therapeutics 05/2024 - 03/2002
4	Immunotherapy 05/2024 - 11/2013
4	Drug Therapy (Chemotherapy) 01/2019 - 03/2002
2	Duration of Therapy 01/2019 - 02/2011